Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole for laryngopharyngeal reflux disease with dry mouth: comparative study
KCT0003888Phase 4Not yet recruiting
- Sponsor
- Il-Yang Pharmaceutical
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ilaprazole in laryngopharyngeal reflux (LPR) and xerostomia, sponsored by Il-Yang Pharmaceutical. Planned start May 2019; status: not yet recruiting.
02
Drugs
ilaprazole
03
Conditions
laryngopharyngeal reflux (LPR)xerostomia
Beyond the preview
Go deeper on KCT0003888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003888.